Robson Classification System Monitoring and Auditing Caesrean Section Rates

Robson Classification System Monitoring and Auditing Caesrean Section Rates in Sohag Governate Hospitals

Robson Classification System Monitoring and Auditing Caesrean Section Rates

Study Overview

• Status: Active, not recruiting
• Conditions: Caesrean Section Rates; Robson Classification
• Intervention / Treatment: Other: just monitoring and auditing ,so there is no intevention

• Study Type: Observational
• Enrollment (Estimated): 300

Contacts and Locations

Study Locations

• Egypt
  • Sohag, Egypt, 82524
    • Sohag University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

pregnant women at >=28 weeks gestaion age.

Description

Inclusion Criteria:

• All pregnant women delivering at ≥ 28 weeks gestation.
• Singleton or multiple pregnancy.
• Cephalic, Breech, or transverse lie.

Exclusion Criteria:

• Gestational age < 28 weeks.
• Intrauterine fetal demises before admission

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Pregnant Women delivering at>28weeks gestaion; Pregnant Women delivering at>28weeks gestaion (interuterine fetal demises before admission are excluded)	Other: just monitoring and auditing ,so there is no intevention; just monitoring and auditing ,so there is no intevention

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in overall Caesarean section rate	All eligible deliveries during the study period will be included (total coverage sampling). Collection of baseline data on mode of delivery. Calculation of CS rate and indications. Classification of women retrospectively into Robson groups. Monthly audit meetings to discuss CS indications per Robson group. Data Collection Data will be collected using a structured sheet including: Maternal age Parity Gestational age Onset of labor Fetal presentation Number of fetuses Mode of delivery Indication of CS Robson group Maternal outcome Neonatal outcome	until 1/february/2027

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Cs rate in each Robson group. Change in primary Cs rate. Change in repeat Cs rate. Matenal morbidity. Neonatal outcomes(Apgar,NICU admission)	Cs rate in each Robson group Change in primary Cs rate. Change in repeat Cs rate. Matenal morbidity. Neonatal outcomes(Apgar,NICU admission)	until 1/february/2027

Collaborators and Investigators

• Sponsor: Sohag University
• Investigators: Study Director: Ahmed Abd El Raheem Ahmed, Sohag University

Study record dates

Study Major Dates

• Study Start (Actual): February 1, 2026
• Primary Completion (Estimated): January 1, 2027
• Study Completion (Estimated): February 1, 2027

Study Registration Dates

• First Submitted: March 18, 2026
• First Submitted That Met QC Criteria: March 25, 2026
• First Posted (Actual): March 31, 2026

Study Record Updates

• Last Update Posted (Actual): March 31, 2026
• Last Update Submitted That Met QC Criteria: March 25, 2026
• Last Verified: March 1, 2026

More Information

Terms related to this study

• Keywords: Robson Classification; Caesrean Section Rates
• Other Study ID Numbers: Soh-Med-26-3-11MS

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No